Search

everythinglearnresearchcommunity

for

Search:↓

QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

A patient with a larger than usual genetic mutation had a broader range of symptoms for a muscle disease.

Scientists created a cell model to study and find treatments for a skin disease called RDEB.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

GT20029 helps regrow hair in men with hair loss and is well-tolerated.

Two siblings with a genetic mutation had a form of rickets that doesn't respond to vitamin D.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

A new gene mutation caused a man's rare skin condition, Schöpf-Schulz-Passarge syndrome.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

A new mutation in the TRPS1 gene was found in a Ukrainian girl with Trichorhinophalangeal syndrome type I.

A specific RNA can help hair growth in baldness by boosting stem cell activity.

A new gene mutation causes vitamin D resistance and rickets, treatable with calcium therapy.

A woman experienced severe side effects from a drug due to a specific genetic variation, suggesting genetic testing could prevent such risks.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

A mutation in the IL2RA gene increases the risk of alopecia areata.

New genetic mutations causing hair loss were found in a Chinese family.